Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities

References

• Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–10.
   PubMed Web of Science ®Google Scholar
• Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2020;75(1):124–137.
   PubMed Web of Science ®Google Scholar
• Cornec D, Cornec-Le Gall E, Fervenza FC, et al. ANCA-associated vasculitis – clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12(10):570–579.
   PubMed Web of Science ®Google Scholar
• Makhzoum JP, Grayson PC, Ponte C, et al. Pulmonary involvement in primary systemic vasculitides. Rheumatology. 2021;61(1):319–330.
   PubMedGoogle Scholar
• Tashiro H, Takahashi K, Tanaka M, et al. Characteristics and prognosis of microscopic polyangiitis with bronchiectasis. J Thorac Dis. 2017;9(2):303–309.
   PubMedGoogle Scholar
• Mohammad AJ, Mortensen KH, Babar J, et al. Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: the influence of ANCA subtype. J Rheumatol. 2017;44(10):1458–1467.
   PubMed Web of Science ®Google Scholar
• Alba MA, Flores-Suarez LF, Henderson AG, et al. Interstitial lung disease in ANCA vasculitis. Autoimmun Rev. 2017;16(7):722–729.
   PubMed Web of Science ®Google Scholar
• Maillet T, Goletto T, Beltramo G, et al. Usual interstitial pneumonia in ANCA-associated vasculitis: a poor prognostic factor. J Autoimmun. 2020;106:102338.
   PubMedGoogle Scholar
• Hozumi H, Kono M, Hasegawa H, et al. Clinical significance of interstitial lung disease and its acute exacerbation in microscopic polyangiitis. Chest. 2021;159(6):2334–2345.
   PubMedGoogle Scholar
• Fernandez Casares M, Gonzalez A, Fielli M, et al. Microscopic polyangiitis associated with pulmonary fibrosis. Clin Rheumatol. 2015;34(7):1273–1277.
   PubMedGoogle Scholar
• Wu TT, Cen ZK, Zhou HJ, et al. Clinical features and survival analysis of microscopic polyangiitis-associated interstitial lung disease: a retrospective study of 28 patients. Zhonghua Jie He He Hu Xi Za Zhi. 2022;45(10):1022–1030.
   PubMedGoogle Scholar
• Komatsu M, Yamamoto H, Kitaguchi Y, et al. Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: a single-center retrospective study. Medicine. 2021;100(13):e25322.
   PubMedGoogle Scholar
• Wu T, Zhang Y, Cen Z, et al. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis. Ther Adv Respir Dis. 2022;16:17534666221140974.
   Google Scholar
• Suzuki A, Sakamoto S, Kurosaki A, et al. Chest high-resolution CT findings of microscopic polyangiitis: a Japanese first nationwide prospective cohort study. AJR Am J Roentgenol. 2019;213(1):104–114.
   PubMed Web of Science ®Google Scholar
• Neel A, Espitia-Thibault A, Arrigoni PP, et al. Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation. Semin Arthritis Rheum. 2018;48(1):70–76.
   PubMed Web of Science ®Google Scholar
• Biedroń G, Włudarczyk A, Wawrzycka-Adamczyk K, et al. Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry. Clin Exp Rheumatol. 2022;40(4):720–726.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhang T, Peng M, et al. Characteristics and prognosis of microscopic polyangiitis patients with diffuse alveolar hemorrhage and interstitial lung disease. Chin Med Sci J. 2022;37(4):293–302.
   PubMedGoogle Scholar
• Travis W D, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748.
   PubMedGoogle Scholar
• Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68.
   PubMed Web of Science ®Google Scholar
• Cottin V, Selman M, Inoue Y, et al. Syndrome of combined pulmonary fibrosis and emphysema: an official ATS/ERS/JRS/ALAT research statement. Am J Respir Crit Care Med. 2022;206(4):e7–e41.
   PubMed Web of Science ®Google Scholar
• Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society white paper. Lancet Respir Med. 2018;6(2):138–153.
   PubMed Web of Science ®Google Scholar
• Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med. 2016;194(3):265–275.
   PubMed Web of Science ®Google Scholar
• Kolb M, Bondue B, Pesci A, et al. Acute exacerbations of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180071.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Hayashi S, Ushiyama O, et al. Development of microscopic polyangiitis in patients with chronic airway disease. Lung. 2005;183(4):273–281.
   PubMed Web of Science ®Google Scholar
• Lhote R, Chilles M, Groh M, et al. Spectrum and prognosis of antineutrophil cytoplasmic antibody-associated vasculitis-related bronchiectasis: data from 61 patients. J Rheumatol. 2020;47(10):1522–1531.
   PubMedGoogle Scholar
• Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society Clinical Practice Guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–1014.
   PubMed Web of Science ®Google Scholar
• Borie R, Crestani B. Antineutrophil cytoplasmic antibody-associated lung fibrosis. Semin Respir Crit Care Med. 2018;39(4):465–470.
   PubMedGoogle Scholar
• Tanaka T, Otani K, Egashira R, et al. Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients. Respir Med. 2012;106(12):1765–1770.
   PubMedGoogle Scholar
• Baqir M, Yi EE, Colby TV, et al. Radiologic and pathologic characteristics of myeloperoxidase–antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(3):195–201.
   PubMed Web of Science ®Google Scholar
• Hosoda C, Baba T, Hagiwara E, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology. 2016;21(5):920–926.
   PubMed Web of Science ®Google Scholar
• Margaritopoulos GA, Vasarmidi E, Jacob J, et al. Smoking and interstitial lung diseases. Eur Respir Rev. 2015;24(137):428–435.
   PubMedGoogle Scholar
• Bellou V, Belbasis L, Evangelou E. Tobacco smoking and risk for pulmonary fibrosis: a prospective cohort study from the UK biobank. Chest. 2021;160(3):983–993.
   PubMedGoogle Scholar
• Mcdermott G, Fu X, Stone JH, et al. Association of cigarette smoking with antineutrophil cytoplasmic antibody-associated vasculitis. JAMA Intern Med. 2020;180(6):870–876.
   PubMedGoogle Scholar
• Villiger PM, Guillevin L. Microscopic polyangiitis: clinical presentation. Autoimmun Rev. 2010;9(12):812–819.
   PubMed Web of Science ®Google Scholar
• Karras A. Microscopic polyangiitis: new insights into pathogenesis, clinical features and therapy. Semin Respir Crit Care Med. 2018;39(4):459–464.
   PubMed Web of Science ®Google Scholar
• Comarmond C, Crestani B, Tazi A, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine. 2014;93(24):340–349.
   PubMed Web of Science ®Google Scholar
• Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–1594.
   PubMed Web of Science ®Google Scholar
• Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021;73(8):1366–1383.
   PubMed Web of Science ®Google Scholar